FDA 503B outsourcing facilities in Alabama
Alabama has 2 FDA-registered 503B outsourcing facilities in the PeptideGrids directory, 1 with FDA drug recalls on record, the earliest registered in 2015. 503B facilities compound sterile medications in bulk under FDA cGMP standards and are a primary supply route for compounded peptides and GLP-1s during drug shortages.
| Facility | City | FDA-registered since | FDA recalls |
|---|---|---|---|
| Eagle Pharma | Birmingham | 2015 | 1 |
| F.H. Investments, Inc. | Birmingham | 2025 | None on record |
503B compounding in Alabama
A 503B outsourcing facility registers with the FDA under the Drug Quality and Security Act and is inspected against cGMP manufacturing standards. In addition to that federal registration, a facility shipping into or operating in Alabama must hold the appropriate state pharmacy license. Verify any facility's current license with the Alabama State Board of Pharmacy.
Peptides and GLP-1s compounded in Alabama
Facilities in Alabama report compounding Semaglutide to the FDA. PeptideGrids grades the clinical evidence for each. Browse the full GLP-1 and therapeutic peptide databases.
Frequently asked questions
How many FDA 503B outsourcing facilities are in Alabama?
2 FDA-registered 503B outsourcing facilities are listed in Alabama on PeptideGrids, the earliest registered in 2015.
Which Alabama 503B facilities have FDA recalls on record?
1 of the 2 Alabama facility has FDA drug recalls on record; the table above shows the count per facility.
How do I verify a pharmacy license in Alabama?
Use the Alabama State Board of Pharmacy license lookup to confirm a facility's current license status.
Facilities sourced from the FDA registered outsourcing facilities list. Recall counts from the FDA openFDA drug enforcement database.